Immunocore Holdings (IMCR) Other financing activities (2023 - 2026)
Immunocore Holdings (IMCR) posted Other financing activities of $656000.0 for Q1 2026, down 84.69% sequentially from $4.3 million in Q4 2025, and down 74.28% YoY from $2.6 million in Q1 2025.
Immunocore Holdings (IMCR) Other financing activities (2023 - 2026) Analysis & Trends
Immunocore Holdings has reported Other financing activities for 4 years, with the latest figure at $656000.0 in Q1 2026.
- Quarterly Other financing activities fell 74.28% year-over-year to $656000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.5 million (up 191.24% YoY) and the FY2025 annual result came in at $12.4 million, up 81.93% from the prior year.
- Other financing activities eased to $656000.0 in Q1 2026 per IMCR's latest filing, from $4.3 million in the prior quarter.
- Over five years, Other financing activities peaked at $11.6 million in Q2 2023 and troughed at $198000.0 in Q3 2024.
- A 4-year average of $4.2 million and a median of $3.7 million in 2025 frame the typical range for Other financing activities.
- The sharpest annual moves came in 2024 and 2025: Other financing activities tumbled 98.09% in 2024, then jumped 1131.54% in 2025.
- Over 4 years, Other financing activities stood at $6.3 million in 2023, then tumbled by 91.21% to $550000.0 in 2024, then soared by 678.91% to $4.3 million in 2025, then tumbled by 84.69% to $656000.0 in 2026.
- According to Business Quant data, Other financing activities over the past three periods registered $656000.0, $4.3 million, and $1.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Immunocore Holdings | 1.76 Bn | 880.92 Mn | 114.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.49 Mn |
| Jun 30, 2026 | 16.49 Mn |
| Mar 31, 2026 | 656,000.00 |
| Mar 31, 2026 | 656,000.00 |
| Dec 31, 2025 | 4.28 Mn |
| Dec 31, 2025 | 4.28 Mn |
| Sep 30, 2025 | 1.87 Mn |
| Sep 30, 2025 | 1.87 Mn |
| Jun 30, 2025 | 3.67 Mn |
| Jun 30, 2025 | 3.67 Mn |
| Mar 31, 2025 | 2.55 Mn |
| Mar 31, 2025 | 2.55 Mn |
| Dec 31, 2024 | 550,000.00 |
| Dec 31, 2024 | 550,000.00 |
| Sep 30, 2024 | 198,000.00 |
| Sep 30, 2024 | 198,000.00 |
| Jun 30, 2024 | 298,000.00 |
| Jun 30, 2024 | 298,000.00 |
| Mar 31, 2024 | 5.75 Mn |
| Mar 31, 2024 | 5.75 Mn |